Natrol Secures Exclusive North American Rights for New Form of Stabilized NADH; New Technology, Available for the First Time in
18 May 2006 - 11:00PM
Business Wire
Natrol, Inc. (NASDAQ:NTOL), a leading manufacturer and distributor
of nationally branded nutritional products, has entered into an
exclusive patent licensing agreement with Oekopharm GmbH of Austria
for the manufacture, sales, distribution and marketing of
nicotinamide adenine dinucleotide hydride (NADH) in North America.
The unique technology (patent pending) stabilizes NADH, which helps
to promote optimal absorption and assures a long, effective shelf
life for Natrol(R) NADH.(a) "The proprietary chlorophyll-based
stabilizing technology behind Natrol NADH helps promote optimal
absorption, allowing individuals to achieve maximum cellular energy
benefits," said Wayne Bos, president and chief executive officer,
Natrol, Inc. "Furthermore, many individuals may appreciate the fact
that Natrol NADH is sugar free and competitively priced."(a)
"Starting a business relationship exclusively with Natrol, Inc.,
was a very important step for our company to enter the United
States market professionally and in a sustainable manner," stated
Norbert Fuchs, founder, and Toby C. Carlin, Jr., spokesperson, of
the Oekopharm-Group, one of Austria's leading companies in
nutriological sciences. "From our experience, stabilized NADH
enhances the activity in organs that develop a high metabolic
turnover, like the brain, the circulation system, and muscles."(a)
In production for the first time in the United States, Natrol's new
NADH will be produced in compliance with the National Nutritional
Foods Association's GMP (Good Manufacturing Practice) standards and
Natrol's own rigorous Quality Assurance practices. Also known as
coenzyme 1, NADH is a highly specialized form of the B-vitamin
niacin that is found in all living cells. It plays a key role in
the energy production of cells and neurotransmitter processes.
Stabilized, intact NADH appears to work by entering "fatigued"
cells to promote cellular energy production in the form of ATP
(adenosine triphosphate), a nucleotide that facilitates
intracellular energy transfer.(a) Natrol is also announcing the
introduction of 10mg NADH and 20mg NADH tablets (a dosage not
previously available on the market). The products will be
distributed in health food stores and online at www.natrol.com. (a)
These statements have not been evaluated by the Food and Drug
Administration. This product is not intended to diagnose, treat,
cure or prevent any disease. About Natrol Founded in 1980, Natrol,
Inc. (NASDAQ:NTOL) is a diversified nutrition company that
manufactures and markets premium-branded nutritional products,
functional teas and sports fitness products under the Natrol(R),
Laci Le Beau(R) Tea and Prolab(R) Sports Nutrition labels. Natrol
markets more than 200 nutritional products designed to meet a wide
range of consumer needs. The products are available at more than
54,000 food, drug, mass market and independent health food stores,
catalogs and Internet sites, gyms and specialty stores nationally
and in select foreign countries. For further information, visit
www.natrol.com.
Natrol (NASDAQ:NTOL)
Historical Stock Chart
From Sep 2024 to Oct 2024
Natrol (NASDAQ:NTOL)
Historical Stock Chart
From Oct 2023 to Oct 2024
Real-Time news about Natrol (MM) (NASDAQ): 0 recent articles
More Natrol, Inc. News Articles